Skip to main content

MoneyWorks4Me

Marksans Pharma informs about press release

07 Aug 2023 Evaluate
Marksans Pharma has informed that it enclosed press release titled ‘Marksaris announces completion of US FDA Post-marketing Adverse Drug Experience (PADE) inspection’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..